- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03066362
Respiratory Variations for Predicting Fluid Responsiveness (ReVaPreF)
April 17, 2026 updated by: University Hospital, Lille
Respiratory Variations of the Inferior Vena Cava and Femoral Artery Flow to Predict Fluid Responsiveness in Spontaneously Breathing Patients With Sepsis, Acute Circulatory Failure, and Regular Cardiac Rhythm
Hypovolemia and acute circulatory failure affects more than 60% of patients hospitalized in intensive care or resuscitation.
The volume expansion (VE) by fluid replacement therapy is the first treatment improve circulatory function.
However, too much VE can be harmful.
So, the use of dynamic predictive indicators of fluid responsiveness is recommended in patients with sepsis.In patients with spontaneous ventilation, few studies have evaluated these parameters.
In mechanical ventilation, indices based on the respiratory variation of the diameters of vena cava have been studied and validated to predict the response to VE. However there is no similar study in spontaneously breathing patients without ventilatory support.
The investigators hypothesize that the respiratory variations in the IVC diameters and femoral artery flow during standardized respiratory cycles are predictive factors of fluid responsiveness in spontaneously breathing patients with sepsis, acute circulatory failure, and regular cardiac rhythm.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hauts-de-France
-
Lille, Hauts-de-France, France, 59000
- Intensive Care Department, Salengro Hospital, CHU de Lille
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adult patients of the intensive care units of the Lille university-hospital and of the Valenciennes general hospital.
- Age greater than or equal to 18.
- Patient insured
- Spontaneous breathing without ventilatory support or intubation or tracheotomy.
- Regular cardiac rhythm
- Prescription by the physician in charge of the patients of a 500 mL volume expansion in less than 30 minutes.
Patients with sepsis with at least one sign of acute circulatory failure:
- Tachycardia with heart rate> 100/min
- systolic blood pressure <90mmHg or a decrease >40mmHg in previously hypertense patient
- Oliguria <0.5ml/kg/hour for at least one hour
- skin mottling
Exclusion Criteria:
- high-grade aortic insufficiency
- transthoracic echogenicity unsuitable for measuring the stroke volume or inferior vena cava diameters
- clinical signs of active exhalation
- clinical or ultrasonographic evidence of pulmonary edema due to heart failure
- pregnancy
- abdominal compartment syndrome
- Irregular cardiac rhythm
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Echocardiography-Doppler
Ultrasonographic recordings, systemic arterial pressure, heart rate, and respiratory rate are recorded immediately before and after volume expansion (VE), performed as a 30-minute infusion of 500 mL of 4% gelatin.
Inferior Vena Cava diameters are measured during spontaneous and standardized respiratory cycles.
Stroke volume is measured during spontaneous respiratory cycles.
|
Ultrasonographic recordings are recorded immediately before and after volume expansion (VE), performed as a 30-minute infusion of 500 mL of 4% gelatin.
Inferior Vena Cava diameters are measured during spontaneous and standardized respiratory cycles.
Stroke volume is measured during spontaneous respiratory cycles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
"respiratory variations in inferior vena cava diameters" with respect to the response to fluid resuscitation, assessed by the area under the ROC curve
Time Frame: during 30 minutes of the volume expansion
|
during 30 minutes of the volume expansion
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
"respiratory variations the femoral artery flow" with respect to the response to fluid resuscitation, assessed by the area under the ROC curve
Time Frame: during 30 minutes of the volume expansion
|
during 30 minutes of the volume expansion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sebastien Preau, MD, PhD, University Hospital, Lille
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
November 9, 2016
First Submitted That Met QC Criteria
February 27, 2017
First Posted (Actual)
February 28, 2017
Study Record Updates
Last Update Posted (Actual)
April 22, 2026
Last Update Submitted That Met QC Criteria
April 17, 2026
Last Verified
February 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011_10
- 2011-A00990-41 (Other Identifier: ID-RCB number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
Clinical Trials on Echocardiography-Doppler
-
Norwegian University of Science and TechnologyCompletedStable Angina Pectoris | Unstable Angina Pectoris | Acute Myocardial InfarctionNorway
-
University Hospital, Clermont-FerrandCompleted
-
Sohag Universitysohag university hospitalRecruiting
-
Institut universitaire de cardiologie et de pneumologie...RecruitingAortic Valve Stenosis | Prosthesis Failure | Aortic Valve RegurgitationUnited States, Canada
-
Luzerner KantonsspitalInovise MedicalCompletedAntineoplastic Agents | Heart Failure, CongestiveSwitzerland
-
John Paul II Hospital, KrakowRecruitingHeart Failure | Cognitive Impairment | Carotid StenosisPoland
-
Ankara UniversityRecruitingPatent Ductus Arteriosus After Premature BirthTurkey
-
Hospices Civils de LyonCompleted
-
Cliniques universitaires Saint-Luc- Université...CompletedAcute Coronary Syndrome | Emergency Medicine | Unstable Angina | Echocardiography | Non-ST Elevation Myocardial Infarction | Myocardial Infarction (MI) | Tissue Doppler | Cardiac Function TestsBelgium